Ibrutinib 560mg tablets
NHS hospitals in England used £23,860,851 of indicative cost of Ibrutinib 560mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 17.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ibrutinib 560mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ibrutinib 560mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| East Sussex Healthcare Nhs Trust | £829,864 |
| Worcestershire Acute Hpls Nhs Trust | £666,753 |
| Colchester Hospital University Nhs Ft | £665,941 |
| Sheffield Teaching Hospitals Nhs Trust | £658,168 |
| Gloucestershire Hpls Nhs Foundation Trst | £617,492 |
| Barts Health Nhs Trust | £560,874 |
| Royal Devon & Exeter Nhs Foundation Trst | £543,704 |
| Co.durham & Darlington Nhs Foundation Tr | £520,811 |
| United Lincolnshire Hospitals Nhs Trust | £503,642 |
| Shrewsbury & Telford Hospital Nhs Trust | £486,472 |
The primary-care picture
Ibrutinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ibrutinib medicine page.